+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

France In-Vitro Diagnostics Market - Growth, Trends & Forecast (2020 - 2025)

  • PDF Icon


  • 85 Pages
  • March 2020
  • Region: France
  • Mordor Intelligence
  • ID: 4997357
In vitro diagnostic tests are the tests used for in vitro examination of specimens derived from the human body to provide information for screening, diagnosis, or treatment monitoring purposes. The rising prevalence of chronic disease has been the primary driver for the growth of this market. This rising prevalence has increased the demand for early and effective diagnostic tests. The rising prevalence of chronic illnesses have also increased the use of point-of-care (POC) diagnostics. Moreover, the increasing awareness and acceptance of personalized medicine and companion diagnostics have also helped he market growth.

Key Market Trends

Application in Cancer is expected to Cover a Large Share of the Market

A cancer biomarkers are indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology. Such biomarkers are be assayed using in-vitro diagnostic tests in non-invasively collected biofluids like blood or serum.

As per the data by the French national cancer institute, the reported cases of cancer have increased drastically among both men and women. As per a 2019 report by the Institute, the number of cancer cases reported have increased by 65% in men and 95% in women in the past 30 years. Therefore as the cancer incidence is further expected to rise in future, the demand for in-vitro diagnostics for early diagnosis is also expected to rise.

Competitive Landscape

France is a developed region with well-structured healthcare system. As a result, many players in the in-vitro diagnostics market are present in the country. Moreover, some domestic players have also been competing in the France market. These factors have made the region very competitive.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format.
  • 3 months of analyst support.

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Chronic Diseases
4.2.2 Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics
4.2.3 Increasing Use of Point-of-care (POC) Diagnostics
4.3 Market Restraints
4.3.1 Stringent Regulations
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Test Type
5.1.1 Clinical Chemistry
5.1.2 Molecular Diagnostics
5.1.3 Immuno Diagnostics
5.1.4 Other Techniques
5.2 By Product
5.2.1 Instrument
5.2.2 Reagent
5.2.3 Other Product
5.3 By Usability
5.3.1 Disposable IVD Devices
5.3.2 Reusable IVD Devices
5.4 By Application
5.4.1 Infectious Disease
5.4.2 Diabetes
5.4.3 Cancer/Oncology
5.4.4 Cardiology
5.4.5 Other Applications
5.5 By End-users
5.5.1 Diagnostic Laboratories
5.5.2 Hospitals and Clinics
5.5.3 Other End-users
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Becton, Dickinson and Company
6.1.3 BioMerieux
6.1.4 Bio-Rad Laboratories, Inc.
6.1.5 Danaher Corporation
6.1.6 F. Hoffmann-La Roche AG
6.1.7 QIAGEN N.V.
6.1.8 Siemens Healthcare GmbH
6.1.9 Sysmex Corporation
6.1.10 Thermo Fischer Scientific Inc.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • BioMerieux
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Siemens Healthcare GmbH
  • Sysmex Corporation
  • Thermo Fischer Scientific Inc.